Chemed Statistics
Total Valuation
Chemed has a market cap or net worth of $8.64 billion. The enterprise value is $8.60 billion.
| Market Cap | 8.64B |
| Enterprise Value | 8.60B |
Important Dates
The next estimated earnings date is Wednesday, April 23, 2025, after market close.
| Earnings Date | Apr 23, 2025 |
| Ex-Dividend Date | Feb 24, 2025 |
Share Statistics
Chemed has 14.64 million shares outstanding. The number of shares has decreased by -0.09% in one year.
| Current Share Class | 14.64M |
| Shares Outstanding | 14.64M |
| Shares Change (YoY) | -0.09% |
| Shares Change (QoQ) | -1.16% |
| Owned by Insiders (%) | 1.67% |
| Owned by Institutions (%) | 97.56% |
| Float | 14.38M |
Valuation Ratios
The trailing PE ratio is 29.66 and the forward PE ratio is 23.44. Chemed's PEG ratio is 2.29.
| PE Ratio | 29.66 |
| Forward PE | 23.44 |
| PS Ratio | 3.65 |
| Forward PS | 3.30 |
| PB Ratio | 7.67 |
| P/TBV Ratio | 24.54 |
| P/FCF Ratio | 23.47 |
| P/OCF Ratio | 20.68 |
| PEG Ratio | 2.29 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.95, with an EV/FCF ratio of 23.37.
| EV / Earnings | 28.47 |
| EV / Sales | 3.54 |
| EV / EBITDA | 19.95 |
| EV / EBIT | 23.09 |
| EV / FCF | 23.37 |
Financial Position
The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.38 |
| Quick Ratio | 1.22 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | 0.38 |
| Interest Coverage | 209.14 |
Financial Efficiency
Return on equity (ROE) is 27.12% and return on invested capital (ROIC) is 18.56%.
| Return on Equity (ROE) | 27.12% |
| Return on Assets (ROA) | 13.95% |
| Return on Invested Capital (ROIC) | 18.56% |
| Return on Capital Employed (ROCE) | 26.92% |
| Revenue Per Employee | $154,908 |
| Profits Per Employee | $19,242 |
| Employee Count | 15,695 |
| Asset Turnover | 1.46 |
| Inventory Turnover | 156.16 |
Taxes
In the past 12 months, Chemed has paid $97.47 million in taxes.
| Income Tax | 97.47M |
| Effective Tax Rate | 24.40% |
Stock Price Statistics
The stock price has decreased by -8.37% in the last 52 weeks. The beta is 0.43, so Chemed's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -8.37% |
| 50-Day Moving Average | 557.81 |
| 200-Day Moving Average | 561.14 |
| Relative Strength Index (RSI) | 59.91 |
| Average Volume (20 Days) | 117,044 |
Short Selling Information
The latest short interest is 296,729, so 2.03% of the outstanding shares have been sold short.
| Short Interest | 296,729 |
| Short Previous Month | 295,474 |
| Short % of Shares Out | 2.03% |
| Short % of Float | 2.06% |
| Short Ratio (days to cover) | 3.03 |
Income Statement
In the last 12 months, Chemed had revenue of $2.43 billion and earned $302.00 million in profits. Earnings per share was $19.89.
| Revenue | 2.43B |
| Gross Profit | 854.35M |
| Operating Income | 372.28M |
| Pretax Income | 387.17M |
| Net Income | 302.00M |
| EBITDA | 431.03M |
| EBIT | 372.28M |
| Earnings Per Share (EPS) | $19.89 |
Balance Sheet
The company has $178.35 million in cash and $140.84 million in debt, giving a net cash position of $37.51 million or $2.56 per share.
| Cash & Cash Equivalents | 178.35M |
| Total Debt | 140.84M |
| Net Cash | 37.51M |
| Net Cash Per Share | $2.56 |
| Equity (Book Value) | 1.12B |
| Book Value Per Share | 76.87 |
| Working Capital | 109.05M |
Cash Flow
In the last 12 months, operating cash flow was $417.50 million and capital expenditures -$49.53 million, giving a free cash flow of $367.97 million.
| Operating Cash Flow | 417.50M |
| Capital Expenditures | -49.53M |
| Free Cash Flow | 367.97M |
| FCF Per Share | $25.14 |
Margins
Gross margin is 35.14%, with operating and profit margins of 15.31% and 12.42%.
| Gross Margin | 35.14% |
| Operating Margin | 15.31% |
| Pretax Margin | 16.43% |
| Profit Margin | 12.42% |
| EBITDA Margin | 17.73% |
| EBIT Margin | 15.31% |
| FCF Margin | 15.13% |
Dividends & Yields
This stock pays an annual dividend of $2.00, which amounts to a dividend yield of 0.34%.
| Dividend Per Share | $2.00 |
| Dividend Yield | 0.34% |
| Dividend Growth (YoY) | 20.25% |
| Years of Dividend Growth | 10 |
| Payout Ratio | 10.06% |
| Buyback Yield | 0.09% |
| Shareholder Yield | 0.43% |
| Earnings Yield | 3.50% |
| FCF Yield | 4.26% |
Analyst Forecast
The average price target for Chemed is $633.00, which is 7.30% higher than the current price. The consensus rating is "Buy".
| Price Target | $633.00 |
| Price Target Difference | 7.30% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 12, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | May 12, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Chemed has an Altman Z-Score of 14.03 and a Piotroski F-Score of 5.
| Altman Z-Score | 14.03 |
| Piotroski F-Score | 5 |